C. Viscoli

Discipline

Sociologie (1)

Type de document

Articles (12) Recensions (6)

Co-auteur

Date

Source

Mot-clé

Patients (12) Patients (12) Treatment (11) thérapie (8) Therapeutics (8) Trials (6) Use (6) Infections (6) recherche (5) maladie (5) cancer (5) Cancer (5) Aspergillosis (5) Research (5) Organization (5) Mycoses (5) Manufacturers' agents (5) Human beings (5) Leukemia (5) Infection (5) Commission merchants (5) Cancer (5) Research (5) Organization (5) maladie (5) temps (durée) (4) besoin (4) infection (4) Methods (4) Neutropenia (4)

Documents écrit par C. Viscoli (12) | parle de C. Viscoli (0)

Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers.
M. Cornu et al.
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.
F. Tissot et al.
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.
D. Averbuch et al. (2013)
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.
M. Mikulska et al. (2010)
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
C. Viscoli et al. (2009)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
B. De Pauw et al. (2008)
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
B.H. Segal et al. (2008)
A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer
M. Akova et al.
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy
A. Cometta et al.
Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis
J.E. Bennett et al. (2003)
Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups
J.E. Bennett et al. (2003)
Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients
C. Viscoli et al. (2001)